Oncotelic Therapeutics, Inc.
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2017 | $-0.17 | $-5.69 |
| FY2018 | $-0.04 | $-5.12 |
| FY2019 | $-0.04 | $-4.48 |
| FY2020 | $-0.04 | $-1.06 |
| FY2021 | $-0.03 | $-0.58 |
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2017 | $-0.17 | $-5.69 |
| FY2018 | $-0.04 | $-5.12 |
| FY2019 | $-0.04 | $-4.48 |
| FY2020 | $-0.04 | $-1.06 |
| FY2021 | $-0.03 | $-0.58 |